BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11138731)

  • 1. Pharmacological characteristics of inhibitory action of the selective alpha1-antagonist JTH-601 on the positive inotropic effect mediated by alpha1-adrenoceptors in isolated rabbit papillary muscle.
    Qiao X; Norota I; Endoh M
    Jpn J Pharmacol; 2000 Nov; 84(3):301-9. PubMed ID: 11138731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evidence for alpha(1D)-adrenoceptors in the rabbit ventricular myocardium: analysis with BMY 7378.
    Yang HT; Endoh M
    Br J Pharmacol; 1997 Dec; 122(8):1541-50. PubMed ID: 9422797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative inotropic action of alpha-1a adrenoceptor blocking agents: role of adenosine and ATP-sensitive K+ channels.
    Kocić I; Korolkiewicz KZ
    Gen Pharmacol; 1998 Mar; 30(3):351-6. PubMed ID: 9510086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological study on functional significance of alpha 1-adrenoceptor subtypes in mammalian ventricular myocardium].
    Nagashima M
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):940-52. PubMed ID: 7959601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alpha 1A adrenoceptor subtype in production of the positive inotropic effect mediated via myocardial alpha 1 adrenoceptors in the rabbit papillary muscle: influence of selective alpha 1A subtype antagonists WB 4101 and 5-methylurapidil.
    Endoh M; Takanashi M; Norota I
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):578-85. PubMed ID: 1356235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of alpha1B-adrenoceptors in the positive inotropic effect of endogenous noradrenaline in rabbit myocardium.
    Hattori Y; Kanno M
    Eur J Pharmacol; 1997 Jun; 329(2-3):165-8. PubMed ID: 9226409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
    Smith KM; Macmillan JB; McGrath JC
    Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of alpha1-adrenoceptor subtypes in the bovine tail artery.
    Ioudina MV; Dyer DC
    J Vet Pharmacol Ther; 2002 Oct; 25(5):363-9. PubMed ID: 12423227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of alpha1B-adrenoceptors linked to inositol phosphate formation and calcium mobilisation in human astrocytoma U373 MG cells.
    Arias-Montaño JA; Berger VA; Soria-Jasso LE; Young JM
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):533-9. PubMed ID: 10598792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of JTH-601, a novel alpha1-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure.
    Suzuki Y; Kanada A; Okaya Y; Aisaka K; Muramatsu I
    Eur J Pharmacol; 1999 Jun; 374(3):495-502. PubMed ID: 10422795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological differentiation of synergistic contribution of L-type Ca2+ channels and Na+/H+ exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium.
    Talukder MA; Endoh M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):87-96. PubMed ID: 9007847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The positive inotropic effect of alpha 1A-adrenoceptor stimulation is inhibited by 4-aminopyridine.
    Williamson AP; Seifen E; Lindemann JP; Kennedy RH
    Eur J Pharmacol; 1996 May; 304(1-3):73-80. PubMed ID: 8813586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
    Errasti AE; Velo MP; Torres RM; Sardi SP; Rothlin RP
    Br J Pharmacol; 1999 Jan; 126(2):437-42. PubMed ID: 10077236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial alpha 1A-adrenoceptor subtypes in rabbit: differentiation by a selective antagonist, HV723.
    Kohi M; Yang HT; Endoh M
    Eur J Pharmacol; 1993 Nov; 250(1):95-101. PubMed ID: 7907026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of JTH-601, a novel alpha(1)-adrenoceptor antagonist, on prostate function in dogs.
    Suzuki Y; Kanada A; Okaya Y; Aisaka K
    Eur J Pharmacol; 2000 Apr; 394(1):123-30. PubMed ID: 10771044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
    Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
    Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.
    Takahashi M; Taniguchi T; Kanamaru H; Okada K; Muramatsu I
    Life Sci; 2000 Oct; 67(20):2443-51. PubMed ID: 11065167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of (+)-niguldipine on myocardial alpha 1-adrenoceptors in the rabbit.
    Endoh M; Takanashi M; Norota I
    Eur J Pharmacol; 1992 Nov; 223(2-3):143-51. PubMed ID: 1362162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor subtypes involved in the alpha1-adrenoceptor mediated increase in 86Rb+ efflux from the rat heart.
    Andersen GO; Enger M; Skomedal T; Osnes JB
    Jpn J Pharmacol; 1997 Oct; 75(2):171-8. PubMed ID: 9414032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate selectivity of JTH-601-G1, an active metabolite of JTH-601, in dogs.
    Suzuki Y; Kanada A; Okaya Y; Kurahashi Y; Kogayu M; Kobayashi T; Aisaka K
    BJU Int; 2000 Mar; 85(4):542-50. PubMed ID: 10691841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.